Carbapenemase producing Enterobacteriaceae (CPE)

Blackrock Clinic Infection Prevention & Control Carbapenemase producing Enterobacteriaceae (CPE)

In Ireland, the terms carbapenemase producing Enterobacteriaceae (CPE) and carbapenem resistant Enterobacteriaceae (CRE) are often used interchangeably by healthcare workers when referring to a family of bacteria that live in the bowel.

CPE/CRE have developed the ability to become resistant to last-resort powerful antimicrobials known as carbapenems, which makes them more challenging to treat if they go on to cause infection.

This antimicrobial resistance problem was first reported in Ireland in 2009 and is increasing in incidence and has been reported as the cause of outbreaks in healthcare settings.

We screen all high risk patients admitted to Blackrock Clinic for CPE. If CPE is detected the patient is cared for in isolation. We also isolate all direct transfers from other hospitals and nursing homes until the CPE result is confirmed negative.

We have had no hospital acquired CPE patients in Blackrock Clinic to date.

Please refer  to the following fact sheet (Developed by the HSE HCAI/ AMR Implementation Team) for more information: CPE General Information and Background for Patients, Relatives and Healthcare Workers

For further information, please visit the Health Protection Surveillance Centre web site: https://www.hpsc.ie/